Palmitic acid promotes endothelial progenitor cells apoptosis via p38 and JNK mitogen-activated prot

来源 :第五届国际络病学大会 | 被引量 : 0次 | 上传用户:minifeng
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective Recent studies have demonstrated that palmitic acid(PA) could regulate endothelial progenitor cells(EPCs) function(migration,proliferation,survival and angiogenesis) via various signal pathways,but the effect of PA on EPCs apoptosis and associated mechanisms are still elusive.Methods The human EPCs were oltained by Ficoll density gradient centrifugation and cultured in M199 medium containing rh-VEGF(30 ng/ml),rh-b-FGF(6 ng/ml) and 10% fetal bovine serum for 7 days.The adhesive EPCs were harvested,then challenged with different concentrations of PA(ranging from 0 to 800 μmol/L) for 48 h and 400 μmol/L PA for different time periods(ranging from 0 to 60 h) after 12 h synchronization with serum free medium.The EPCs apoptosis was determined by flow cytometry,expression of caspase3,phosphorylated ERK1/2,JNK and p38 mitogen-activated protein kinase(MAPK) were quantified by Western-blot.The effect of PA on caspase-3 activity in the absence or presence of specific MAPK pathway inhibitors was determined by colorimetry.Results PA increased EPCs apoptosis in a dose-and time-dependent manner,upregulated phosphorylated p38 and JNK,caspase-3 expression of EPCs while ERK expression was not affected.PA induced EPCs apoptosis could be partly ameliorated by p38 inhibitor SB203580 and JNK inhibitor SP600125,but not by ERK1/2 inhibitor PD98059.Conclusion These findings suggested that PA promoted EPCs apoptosis via p38 and JNK MAPKs pathways.
其他文献
证候研究是中医现代研究的核心内容,是带动中医药基础理论取得突破性进展和促进中医药现代化的关键问题之一。国家和多学科研究者始终不遗余力地对证候概念、证候规范化和证候科学本质进行研究,取得了一些阶段性成果,但依然存在一些棘手的问题。近年来,复杂科学、系统生物学理论的兴起及代谢组学方法在中医证候实质研究中的应用日趋受到重视,中医药现代化研究出现新的发展契机。
目的:分别观察桂龙通络胶囊、中药足浴配合弥可保治疗糖尿病周围神经病变(DPN)的疗效.方法:将86例DPN患者随机分为2组,治疗组60例、对照组26例.2组均以西药控制血糖,弥可保片500μg,每天3次口服,治疗组又分为2组,治疗1组在对照组治疗基础上加桂龙通络胶囊每次4粒,每日3次口服,治疗2组在对照组治疗基础上加中药浸泡双足.2组疗程均为2月.结果:治疗组和对照组神经传导速度均高于治疗前(P<
目的:探讨参松养心胶囊联合通心络胶囊,治疗冠心病心力衰竭伴室性早搏的临床效果.方法:112例患者随机分成2组.治疗组(58例):口服参松养心胶囊3粒,每日3次,通心络胶囊3粒,每日3次;对照组(54例):口服普罗帕酮100 mg,每日3次,复方丹参片3片,每日3次.疗程均为1个月.结果:室性早搏治疗组与对照组总有效率分别为84.5%和75.9%,差异无统计学意义(P>0.05);Holter记录室
目的:研究益气通络法对颈动脉粥样硬化的作用.方法:100例颈动脉粥样硬化随机进入治疗组和对照组各50例,对照组予以基础治疗,治疗组在基础治疗上加服通心络胶囊4粒,每日3次,治疗4周为1疗程,连续3个疗程.观察治疗前后彩色多普勒超声颈动脉内中膜的变化以及血脂的变化及安全性指标.结果:治疗组治疗前后颈动脉内中膜厚度和血脂变化差异有统计学意义(P<0.05),对照组治疗前后差异无统计学意义(P>0.05
Objective Tongxinluo(TXL) is a traditional Chinese herbal medicine with multiple biological activity.Dendritic cells(DC),which are professional antigen-presenting cells,were recently detected in ather
Objective To investigate the effect and the potential mechanism of TXL on aortic biological variation and plasma or tissue factor in Ang Ⅱ induced a deficiency condition of rat contributed to the deve
Objective Advanced glycation end products(AGEs) and endothelial progenitor cells(EPCs) play key roles in pathogenesis of diabetes-related vascular complications.AGEs can induce EPCs dysfunction.The pe
Objective Advanced glycation end products(AGEs) and vascular adveentitial fibroblasts(AFs) are involved in diabetes-related vascular complications.However,the effect of AGEs on AFs remains unclear.The
Objective Advanced glycation end products(AGEs) and endothelial progenitor cells(EPCs) play divergent roles in the process of atherosclerosis.We investigated the effects of AGE-human serum albumin(AGE
会议